Medicine – Idiopathic Intracranial Hypertension

Idiopathic intracranial hypertension (IIH) is the modern term for what was traditionally called benign intracranial hypertension or pseudotumor cerebri. It is characterised by raised intracranial pressure without an intracranial mass lesion, hydrocephalus, or another obvious structural cause.

The term “benign” is now avoided because the condition can threaten vision through persistent papilloedema and optic nerve damage.

1. Basic Definition

IIH is diagnosed when intracranial pressure is raised but brain imaging shows no mass lesion or hydrocephalus, and CSF composition is otherwise normal.

Therefore:

Raised intracranial pressure + normal brain structure apart from secondary imaging signs + normal CSF composition = consider IIH.

2. Typical Patient

IIH occurs most commonly in:

Women of reproductive age who are overweight or have obesity.

Obesity is one of the strongest associations.

Weight gain before symptom onset is also common.

3. Obesity

Obesity is the major modifiable risk factor.

The older figure of 90% is not appropriate as a universal rule, but a large proportion of patients with typical IIH are overweight or obese.

This is why weight reduction is an important part of treatment.

4. Secondary Intracranial Hypertension

Before diagnosing idiopathic intracranial hypertension, secondary causes of raised intracranial pressure should be excluded.

Important medication or metabolic associations include:

Vitamin A excess and retinoids.

Tetracyclines.

Growth hormone in some cases.

Certain endocrine or systemic disorders.

Some older lists include oral contraceptive pills, but the causal association with OCPs is much less convincing than with obesity, retinoids, and tetracyclines.

5. Vitamin A

Excess vitamin A can cause intracranial hypertension.

This is particularly relevant with:

Vitamin A toxicity.

Retinoid medications such as isotretinoin.

The original note also mentions vitamin A deficiency, but vitamin A excess is the much more established association with intracranial hypertension.

6. Tetracyclines

Tetracycline-class antibiotics can precipitate intracranial hypertension.

Examples include:

Tetracycline.

Doxycycline.

Minocycline.

The combination of a tetracycline with a retinoid is particularly concerning.

7. Headache

Headache is one of the most common symptoms.

It may be:

Daily or near-daily.

Pressure-like or throbbing.

Worse on waking.

Worse with coughing, straining, or bending.

Associated with nausea.

However, the headache phenotype can overlap with migraine.

8. Papilloedema

Papilloedema is one of the key findings.

Remember:

Papilloedema = optic-disc swelling caused by raised intracranial pressure.

It is usually bilateral.

Fundoscopy may show:

Blurred optic-disc margins.

Disc elevation.

Venous congestion.

Peripapillary haemorrhages in more severe cases.

9. Visual Symptoms

Patients may describe:

Transient visual obscurations.

These are brief episodes of dimming or blackout of vision, often lasting seconds.

They may be triggered by:

Standing.

Bending.

Postural change.

They reflect pressure effects on the optic nerve.

10. Visual Field Defects

Persistent raised intracranial pressure can damage the optic nerves.

Visual field abnormalities may include:

Enlargement of the blind spot.

Peripheral field loss.

Arcuate defects.

Scotomas.

If untreated, severe optic nerve damage can produce permanent visual loss.

11. Sixth Cranial Nerve Palsy

A sixth cranial nerve palsy can occur because CN VI has a long intracranial course and is vulnerable to stretching when intracranial pressure rises.

This may produce:

Horizontal diplopia.

The affected eye has impaired abduction.

Therefore:

Raised ICP + papilloedema + horizontal diplopia → think possible CN VI palsy.

12. Pulsatile Tinnitus

A common associated symptom is:

Pulsatile tinnitus.

Patients may describe hearing a:

Whooshing or heartbeat-like sound.

This can be unilateral or bilateral.

It is a useful clinical clue in IIH.

13. Neurological Examination

Apart from papilloedema and occasionally a sixth nerve palsy, the neurological examination is usually:

Normal.

This helps distinguish IIH from many structural intracranial disorders.

14. Brain Imaging

Brain imaging is essential before lumbar puncture.

MRI brain is often preferred.

The purpose is to exclude:

Intracranial mass lesion.

Hydrocephalus.

Structural brain disease.

Cerebral venous sinus thrombosis.

15. MR Venography

Venous imaging is important because cerebral venous sinus thrombosis can mimic IIH.

Therefore, MRI is commonly combined with:

MR venography.

This helps exclude a secondary cause of raised intracranial pressure.

16. Imaging Is Not Always Completely “Normal”

The original note says the brain scan is normal.

It is more accurate to say:

No mass lesion or hydrocephalus is present.

However, imaging may show secondary signs of raised intracranial pressure such as:

Empty or partially empty sella.

Flattening of the posterior globe.

Distension of the optic nerve sheath.

Transverse venous sinus stenosis.

These support the diagnosis but are not required in every case.

17. Lumbar Puncture

After appropriate brain imaging, lumbar puncture is performed.

The key findings are:

Raised opening pressure.

Normal CSF composition.

Opening pressure should be measured carefully in the lateral decubitus position.

18. Opening Pressure

The older cutoff of:

>200 mmH₂O

is too low as a general adult threshold.

In adults, an opening pressure of approximately:

≥250 mmH₂O

is generally considered abnormally elevated in the appropriate clinical context.

Values must still be interpreted with technique, body habitus, symptoms, and other findings in mind.

19. CSF Composition

In IIH, CSF should otherwise be normal.

Therefore there should not be an unexplained:

Pleocytosis.

Marked protein elevation.

Low glucose.

Abnormal CSF composition should prompt reconsideration of the diagnosis.

20. Diagnostic Pattern

The diagnosis rests on the combination of:

Symptoms/signs of raised intracranial pressure.

Papilloedema.

Normal neurological examination except possible CN VI palsy.

No mass lesion or hydrocephalus on imaging.

No cerebral venous sinus thrombosis.

Raised lumbar puncture opening pressure.

Normal CSF composition.

21. Weight Loss

Weight reduction is one of the most important treatments in overweight patients.

Even modest sustained weight loss can improve:

Headache.

Papilloedema.

Intracranial pressure.

Visual outcomes.

Therefore, weight management is a disease-modifying component of treatment.

22. Acetazolamide

Acetazolamide is the classic medical treatment.

It is a:

Carbonic anhydrase inhibitor.

It reduces CSF production at the choroid plexus.

Therefore:

Acetazolamide → ↓ CSF production → ↓ intracranial pressure.

23. Adverse Effects of Acetazolamide

Important adverse effects include:

Paraesthesia.

Fatigue.

Taste disturbance.

Renal stones.

Metabolic acidosis.

Electrolyte disturbance.

Tolerance can limit treatment in some patients.

24. Topiramate

Topiramate is sometimes used in selected patients.

It may help because it can:

Reduce headache frequency.

Promote weight loss.

and has some carbonic anhydrase-inhibiting activity.

It is particularly useful when the headache phenotype has migraine-like features.

25. Serial Lumbar Punctures

The original note lists:

Sequential lumbar puncture.

Repeated lumbar punctures can temporarily lower pressure, but the effect is usually short-lived because CSF is rapidly replaced.

Therefore, serial lumbar puncture is generally not preferred as routine long-term treatment.

It may be used temporarily in selected situations while definitive management is being arranged.

26. Vision Monitoring

Because permanent visual loss is the major feared complication, patients require formal ophthalmic monitoring.

This may include:

Visual acuity.

Visual fields.

Fundoscopy.

Optical coherence tomography, OCT.

The purpose is to detect progression of papilloedema or optic nerve damage early.

27. When Surgery Is Needed

Surgical treatment is considered when:

Vision is rapidly deteriorating.

Papilloedema is severe despite medical therapy.

Intracranial pressure remains uncontrolled.

The goal is primarily to protect vision.

28. CSF Shunting

CSF diversion may be performed using:

Ventriculoperitoneal shunting.

or

Lumboperitoneal shunting.

The choice depends on local expertise and the individual patient.

Shunts reduce intracranial pressure by diverting CSF.

29. Optic Nerve Sheath Fenestration

Another surgical option is:

Optic nerve sheath fenestration.

This is particularly considered when:

Visual deterioration is the dominant problem.

It aims to relieve pressure around the optic nerve and protect vision.

30. Venous Sinus Stenting

In carefully selected patients with significant venous sinus stenosis and a relevant pressure gradient, venous sinus stenting may be considered in specialist centres.

It is not required for every patient with IIH.

31. Prognosis

The condition may improve with treatment, especially with successful weight loss and control of intracranial pressure.

However, persistent papilloedema can lead to:

Optic atrophy.

Permanent visual field loss.

Permanent visual impairment.

This is why the old term “benign intracranial hypertension” is misleading.

32. Idiopathic Intracranial Hypertension – Note Form

Old name: benign intracranial hypertension / pseudotumor cerebri.

Definition: raised intracranial pressure without mass lesion, hydrocephalus, or another identifiable structural cause.

Typical patient: overweight woman of reproductive age.

Major association: obesity.

Important drug associations: tetracyclines and vitamin A/retinoids.

Headache: common.

Papilloedema: classic sign.

Visual symptoms: transient visual obscurations, blind-spot enlargement, field defects, scotomas.

CN VI palsy: may cause horizontal diplopia.

Pulsatile tinnitus: common useful clue.

Imaging: no mass lesion/hydrocephalus; exclude venous sinus thrombosis.

CSF: normal composition with elevated opening pressure.

Adult opening pressure: usually ≥250 mmH₂O supports the diagnosis.

Treatment: weight loss + acetazolamide.

If vision threatened: surgical CSF diversion or optic nerve sheath fenestration may be needed.

33. Important Corrections to the Original Notes

“Benign intracranial hypertension” → better called idiopathic intracranial hypertension.

OCP: not considered a strong established causal association compared with obesity, retinoids, and tetracyclines.

Vitamin A: excess is the important association; deficiency is not a standard classic cause of IIH.

Brain scan: not necessarily completely normal; secondary signs of raised ICP may be present.

Opening pressure >200 mmH₂O: modern adult diagnostic threshold is generally closer to ≥250 mmH₂O.

Sequential lumbar punctures: may give temporary relief but are not preferred routine long-term therapy.

Key Clinical Pattern

Think of IIH as:

OVERWEIGHT YOUNG WOMAN + HEADACHE + PAPILLOEDEMA + PULSATILE TINNITUS ± CN VI PALSY.

The investigation pattern is:

MRI/MRV → no mass or hydrocephalus, exclude venous sinus thrombosis.

Lumbar puncture → raised opening pressure + normal CSF composition.

The treatment pattern is:

WEIGHT LOSS + ACETAZOLAMIDE.

And the most important complication is:

PERSISTENT PAPILLOEDEMA → OPTIC NERVE DAMAGE → PERMANENT VISUAL LOSS.